PathoQuest
FranceWho owns PathoQuest?
PathoQuest is a French Biotech company, now owned by Charles River Laboratories, which acquired it in 2026 from SHS Gesellschaft für Beteiligungsmanagement.
Turenne Groupe is still listed as an investor in PathoQuest, status not confirmed after the 2026 sale.
Hand-verified · updated 2026-04-21
Open JSON · CC-BY
Key facts
Ownership history
2 ownership periods · co-invest detected
SHS Gesellschaft für Beteiligungsmanagement sold PathoQuest to Charles River Laboratories in 2026 after 5 years.
More from Capital Santé 2
Other portfolio companies in the same fund.
More PE-backed in Biotech
Comparable biotech deals from other GPs.
USQuestions
Who owns PathoQuest?
PathoQuest is now owned by Charles River Laboratories, which acquired it in 2026 from SHS Gesellschaft für Beteiligungsmanagement. Turenne Groupe is still listed as an investor in PathoQuest, status not confirmed after the 2026 sale.
When did Charles River Laboratories acquire PathoQuest?
Charles River Laboratories acquired PathoQuest in 2026, buying from SHS Gesellschaft für Beteiligungsmanagement.
Who did PathoQuest sell to?
SHS Gesellschaft für Beteiligungsmanagement sold PathoQuest to Charles River Laboratories in 2026 (Trade Sale).
Who has owned PathoQuest over time?
PathoQuest has been through 2 private-equity ownership periods: SHS Gesellschaft für Beteiligungsmanagement · via SHS V · 2021–2026 · sold to Charles River Laboratories · (Trade Sale); Turenne Groupe · via Capital Santé 2 · since 2021.